§471-11 / §280E COGS Review & Adjustment Memo
| Entity | EIN (example) | Inventory role | Governing COGS rule |
|---|---|---|---|
| Northgate Cultivation LLC | 88-0000000 | Producer (cultivator) | Full absorption — Treas. Reg. §1.471-11 |
| Northgate Retail LLC | 88-0000001 | Reseller (dispensary) | Invoice + freight-in — Treas. Reg. §1.471-3 |
| Northgate Holdings LLC | 88-0000002 | Ancillary (no inventory) | Not a §280E business — deductions allowed |
Engagement routing. Tier: COGS method review (Seq. 1 of transition plan) · Posture: Mixed (medical + adult-use) · Active IRS matter: No · Services indicated: Schedule III Transition Planning · §471(c) / 8275-R Return Disclosure · prior-year §471 refund-claim review
Prepared for the named operator as a scoped COGS method review, following the §280E Risk Review. This example is illustrative and does not constitute tax or legal advice to any reader; no client relationship is created by viewing it. COGS positions are a matter of recomputation against real books and current authority; nothing here is a promised outcome. Method positions, where they depart from a regulation, are disclosed on the return, and any prior-year adjustment is engaged separately under an engagement letter.
More cost belongs in COGS — defensibly
Under §280E, only cost of goods sold survives for Northgate's plant-touching entities, so the entire recoverable position is how much legitimate production cost is captured in COGS. The cultivation entity is a producer and may absorb a full range of indirect production costs under Treas. Reg. §1.471-11 — costs it is currently leaving on the deduction side, where §280E disallows them. The recomputation moves those costs into COGS, applies a defensible medical/adult-use allocation, and leaves a clean audit trail.
Reclassifying under-absorbed indirect production costs into COGS appears to reduce the §280E disallowance by ~$60,000–$150,000 per year. This is a mechanism illustration, not a conclusion — the real figure appears only after the sample review and reconciliation, and rests on §471 costing, not §263A (see Analysis).
The operation and its costs
Facts below are as reported by the operator and are illustrative; they are verified during the engagement.
Client summary
A boutique California grow — roughly 10,000 sq ft of canopy, about $620,000 in annual gross receipts — with both medical and adult-use cultivation designations and an adult-use retail license. Cultivation is a producer; retail is a reseller; the two are governed by different COGS rules.
Business lines
- Cultivation — plant-touching producer; full-absorption COGS under §1.471-11.
- Retail — plant-touching reseller; limited COGS (invoice + freight-in) under §1.471-3.
- Holding — ancillary, non-plant-touching; ordinary deductions allowed (separate trade or business).
Revenue streams
Bulk adult-use flower (majority), medical flower, and trim/biomass from cultivation; retail counter sales; intercompany rent to the holding entity. The medical and adult-use split drives the allocation study.
Cost structure
Direct production costs (seeds/clones, grow labor, nutrients) are captured; the gaps are indirect production costs — cultivation facility rent and utilities, indirect labor, depreciation on grow equipment, quality control, and supervisory time — that §1.471-11 permits a producer to absorb but that Northgate currently expenses (and therefore forfeits under §280E).
The costing method, step by step
COGS methodology (§471-11(c))
As a producer, Northgate Cultivation applies the full-absorption method of Treas. Reg. §1.471-11. Under §1.471-11(c)(2), indirect production costs fall in three buckets: category 1 costs that must be inventoried, category 3 costs that need not be, and category 2 costs included only if the taxpayer's financial statements treat them as inventoriable (the book-conformity rule). The review works each GL account into the correct category and pulls the category 1 and elected category 2 costs into COGS.
§263A cannot expand a cannabis operator's COGS. UNICAP capitalizes costs only to the extent they are otherwise deductible; §280E denies the deduction, so §263A pulls nothing extra into inventory. That is the Harborside (Patients Mutual) holding, and it is why a cannabis producer's COGS rests on §471 / §1.471-11 full absorption, not §263A. A reseller is narrower still — §1.471-3 limits its COGS to invoice price plus freight-in.
Transition go-forward: once cannabis is rescheduled to Schedule III and §280E lifts, the COGS-vs-deduction line stops mattering going forward — every ordinary business expense becomes deductible. Until then, and for any open prior year, the §1.471-11 method work is the whole game. The method built here is the foundation the transition plan switches from.
Allocation assumptions
Two allocations run. First, the medical vs adult-use split — both plant-touching, so this allocates shared production cost between product lines on a canopy square-footage basis, the more defensible measure for cultivation. Second, the §280E line vs non-§280E line split — shared overhead is allocated between the plant-touching businesses (COGS-only) and the ancillary holding business (deductible), on the separate-trade-or-business principle of CHAMP. Bases are documented, not assumed.
Expense classification review
Each expense account is reviewed and reclassified: production vs period, direct vs indirect, §1.471-11 category, and §280E line vs non-§280E line. A sample is pulled and tested (Exhibit D). Misclassified period costs stay out of COGS — over-inclusion is as much an exam risk as under-inclusion.
Risk areas
- Over-inclusion. Pushing non-production period costs into COGS invites disallowance; the method is defensible only if the line holds both ways.
- Book conformity. Category 2 costs must match financial-statement treatment (§1.471-11(c)(2)(iii)); inconsistency undercuts the position.
- Change in method. Correcting the costing method may require a §446 change with a §481(a) adjustment rather than a simple restatement.
- Reseller reach. Retail COGS cannot be inflated beyond §1.471-3; only cultivation gets full absorption.
Recommended adjustments
Reclassify the identified indirect production costs into cultivation COGS under §1.471-11; apply the square-footage and CHAMP allocations; leave retail COGS on §1.471-3; document each move to the account and authority. Detail and owners are in Recommendations and Exhibit A.
Implementation notes
Implement via a corrected chart of accounts (Exhibit C) and, where the correction is a method change, a Form 3115 with the §481(a) adjustment. Where a position departs from a regulation, disclose on Form 8275-R. Prior-year corrections are filed only within the §6511 window and only where defensible.
Final conclusions
A materially larger, defensible COGS position is available to the cultivation entity under §1.471-11 — not by stretching §263A, but by correctly absorbing indirect production costs the operator already incurs. The retail entity's COGS is correctly limited. The method, once corrected, carries into both the go-forward transition and any prior-year claim.
§280E / COGS issue register
Controlling authority or evidence type is flagged for each item. Conclusions are illustrative and not asserted until run against real books. Exposure bands are order-of-magnitude illustrations, not estimates for any taxpayer.
| Issue | Controlling authority / evidence | Illustrative exposure band | Priority |
|---|---|---|---|
| Indirect production costs expensed, not absorbed into COGS | Treas. Reg. §1.471-11(c)(2); IRC §471 | ~$60k–$150k / yr overpaid | High |
| Medical / adult-use allocation lacks square-footage support | Evidence: canopy records, Metrc; IRC §280E | ~$25k–$70k / yr | High |
| Reliance on §263A to expand COGS (unavailable) | IRC §263A; Harborside (Patients Mutual) | Position fails if asserted | Elevated |
| Shared overhead not split on the CHAMP basis | CHAMP v. Commissioner; separate trade or business | Allocation exposure | Elevated |
| Correction may be a method change (§446 / §481(a)) | IRC §446; §481(a); Form 3115 | Procedural — timing | Review |
| Over-inclusion of period costs in COGS | Treas. Reg. §1.471-11; exam risk | Disallowance if overstated | Guardrail |
Adjustments, with owner and deadline
Owners and targets are placeholders; real sequencing follows the sample review.
| Adjustment | Effect | Owner | Target |
|---|---|---|---|
| Absorb category 1 indirect production costs into cultivation COGS | Reduces §280E disallowance (§1.471-11) | J. Williams, EA | [+21 days] |
| Elect + document category 2 costs to book treatment | Adds book-conformed costs to COGS | EA + controller | [+30 days] |
| Apply square-footage medical/adult-use allocation | Defensible product-line split | J. Williams, EA | [+30 days] |
| Apply CHAMP overhead split (§280E vs non-§280E) | Correct deductible vs COGS-only | J. Williams, EA | [+30 days] |
| File Form 3115 for the method change (if required) | §481(a) adjustment; clean go-forward | J. Williams, EA | [next return] |
- Do not rely on §263A to pull additional costs into COGS — it does not apply where §280E denies the deduction.
- Do not inflate retail (reseller) COGS beyond §1.471-3.
- Keep period costs out of COGS — over-inclusion is an exam risk.
Supporting shells
Exhibit A — COGS schedule (cultivation)
| Cost category | §1.471-11 treatment | In COGS? | Illustrative amount |
|---|---|---|---|
| Seeds / clones, nutrients (direct materials) | Direct production cost | Yes | $— |
| Grow / cultivation labor (direct) | Direct production cost | Yes | $— |
| Cultivation rent, utilities | Category 1 indirect | Yes (add) | $— |
| Depreciation — grow equipment | Category 1 indirect | Yes (add) | $— |
| Quality control, supervisory labor | Category 1 indirect | Yes (add) | $— |
| Selling, general marketing | Period cost | No (§280E-disallowed) | $— |
Exhibit B — Allocation worksheet (§280E-line vs non-§280E-line)
| Shared cost | Allocation basis | §280E line (COGS-only) | Non-§280E line (deductible) |
|---|---|---|---|
| Facility rent | Square footage | Cultivation / retail share | Holding / office share |
| Admin / bookkeeping | Time + headcount | Plant-touching share | Ancillary share |
| Insurance | Coverage by activity | Plant-touching share | Ancillary share |
Exhibit C — Chart-of-accounts mapping
| GL account | §1.471-11(c) category | COGS-includible? | Note |
|---|---|---|---|
| Cultivation rent | Category 1 | Yes | Producer indirect |
| Grow-room utilities | Category 1 | Yes | Producer indirect |
| Repairs / maintenance (grow) | Category 2 | If booked to inventory | Book conformity |
| Officer / marketing salaries | Category 3 / period | No | §280E-disallowed |
Exhibit D — Expense sample review
| Expense (sample) | Amount (illustrative) | Current | Recommended |
|---|---|---|---|
| Grow-room HVAC utilities | $— | Period expense | COGS (Cat 1) |
| Cultivation supervisor wages | $— | Period expense | COGS (Cat 1) |
| Retail counter software | $— | Period expense | No change (reseller) |
| Brand advertising | $— | Period expense | No change (§280E) |
Exhibit E — §280E risk table
| Position | Likelihood challenged | Impact | Posture |
|---|---|---|---|
| Category 1 indirect absorption (§1.471-11) | Low | High | Defensible |
| Category 2 book-conformed costs | Medium | Medium | Document |
| Medical/adult-use allocation | Medium | Medium | Support |
| Any §263A-based expansion | High | High | Do not assert |
Findings, actions, and what's open
- Indirect production costs are expensed, not absorbed — the main overpayment.
- COGS rests on §471 / §1.471-11, not §263A (Harborside).
- Cultivation gets full absorption; retail is limited to §1.471-3.
- Allocations run on square footage (product lines) and CHAMP (§280E vs non-§280E).
- Reclassify category 1 (and elected category 2) costs into COGS.
- Document both allocations with source records.
- File Form 3115 for the method change if required.
- Disclose reg-contrary positions on Form 8275-R.
- Next return — adjustments + disclosure attached.
- §6511 window — for any prior-year correction.
- Method-change filing (Form 3115), if applicable.
- General ledger + trial balance for the sample review.
- Canopy measurements for the allocation.
- Financial statements for the category 2 book-conformity test.
Get your COGS recomputed under §471-11
A licensed Enrolled Agent rebuilds your full-absorption COGS, runs the medical/adult-use and §280E allocations, and hands you a defensible, documented method — not a §263A stretch that fails on exam. Start with a consult.
Book a COGS review consult →Single-location California operators · EA-signed, exam-ready